会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Double-acylated GLP-1 derivatives with a linker
    • 具有接头的双酰化GLP-1衍生物
    • US09006178B2
    • 2015-04-14
    • US13883946
    • 2011-11-09
    • Jacob KofoedJesper LauLars LinderothPatrick William GaribayThomas Kruse
    • Jacob KofoedJesper LauLars LinderothPatrick William GaribayThomas Kruse
    • A61K38/26A61P3/10A61P7/12C07K14/605A61K38/28C07K5/00C07K7/00C07K16/00C07K17/00A61K47/48
    • C07K14/605A61K47/542
    • The invention relates to a derivative of a GLP-1 analog, which analog comprises a first K residue at a position corresponding to position 18 of GLP-1(7-37) (SEQ ID NO: 1), a second K residue at another position, and a maximum of twelve amino acid changes as compared to GLP-1(7-37); which derivative comprises two protracting moieties attached to said first and second K residue, respectively, via a linker, wherein the protracting moiety is selected from Chem. 1: HOOC—(CH2)x—CO—*, and Chem. 2: HOOC—C6H4-0-(CH2)y—CO—*, in which x is an integer in the range of 6-18, and y is an integer in the range of 3-17; and the linker comprises Chem. 3: *—NH—(CH2)q—CH[(CH2)w—NH2]—CO—*, wherein q is an integer in the range of 0-5, and w is an integer in the range of 0-5; or a pharmaceutically acceptable salt, amide, or ester thereof. The invention also relates to the pharmaceutical use thereof, for example in the treatment and/or prevention of all forms of diabetes and related diseases, as well as to corresponding novel peptides and side chain intermediates. The derivatives are potent, protracted, and suitable for oral administration.
    • 本发明涉及GLP-1类似物的衍生物,其类似物包含在对应于GLP-1(7-37)(SEQ ID NO:1)的第18位的位置处的第一个K残基,另一个的第二个K残基 位置和与GLP-1(7-37)相比最多12个氨基酸变化; 该衍生物分别包含通过接头分别连接到所述第一和第二K残基的两个伸长部分,其中伸长部分选自Chem。 1:HOOC-(CH 2)x-CO- *,和Chem。 2:HOOC-C6H4-0-(CH2)y-CO- *,其中x是6-18的整数,y是3-17的整数; 连接体包括Chem。 3:* -NH-(CH 2)q-CH [(CH 2)w -NH 2] -CO- *,其中q是0-5的整数,w是0-5的整数 ; 或其药学上可接受的盐,酰胺或酯。 本发明还涉及其药物用途,例如用于治疗和/或预防所有形式的糖尿病和相关疾病,以及相应的新型肽和侧链中间体。 衍生物有效,延长,适合口服。